Health Care & Life Sciences » Pharmaceuticals | Aeglea BioTherapeutics Inc.

Aeglea BioTherapeutics Inc. | Key People and Executives

Anthony G. Quinn
President, Chief Executive Officer & Director
V. Bryan Lawlis
Director
George Georgiou
Director
Armen B. Shanafelt
Chairman
Ivana Magovcevic-Liebisch
Independent Director
Suzanne Louise Bruhn
Independent Director
Russell J. Cox
Independent Director
Sandesh Mahatme
Independent Director
Anthony G. Quinn
President, Chief Executive Officer & Director
Charles N. York
Chief Financial Officer & Vice President
James Wooldridge
Chief Medical Officer
Scott W. Rowlinson
Vice President-Research
Aaron Schuchart
Chief Business Officer
Joseph E. Tyler
Vice President-Manufacturing
V. Bryan Lawlis
Director
David G. Lowe
Co-Founder
George Georgiou
Director
David C. Mitchell
Vice President-Regulatory Affairs & Quality
Armen B. Shanafelt
Chairman
Ivana Magovcevic-Liebisch
Independent Director
Suzanne Louise Bruhn
Independent Director
Russell J. Cox
Independent Director
Sandesh Mahatme
Independent Director

About Aeglea BioTherapeutics

View Profile
Address
Barton Oaks Plaza One
Austin Texas 78746
United States
Employees -
Website http://www.aegleabio.com
Updated 07/08/2019
Aeglea Biotherapeutics, Inc. is a clinical-stage biotechnology company, which engages in the design and development of human enzyme therapeutics for patients with rare genetic diseases and cancer. It develops pegzilarginase, its lead investigational therapy, for the treatment of Arginase 1 Deficiency, as monotherapy in arginine-dependent cancers and in combination with an immune checkpoint inhibitor for small cell lung cancer. The company was founded by George Georgiou and David G.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.